David G. Poplack, M.D., has served as Director of Texas Children’s Cancer Center since 1993. He holds the Elise C. Young Chair of Pediatric Oncology and is Chief of the Hematology-Oncology Service in the Department of Pediatrics at Baylor College of Medicine. He is also the Deputy Director of the Dan L. Duncan Cancer Center at Baylor College of Medicine, an NCI-designated Cancer Center.

Prior to joining Texas Children’s and Baylor College of Medicine, Dr. Poplack was Deputy Branch Chief of the Pediatric Branch of the National Cancer Institute, where he was a senior investigator and head of the Clinical Pharmacology and Experimental Therapeutics Section.

Dr. Poplack is a graduate of Tufts University. He received his M.D. degree from Boston University School of Medicine, completed his pediatric internship at Stanford University, his residency in pediatrics at the Children’s Hospital in Boston, and his fellowship in pediatric hematology-oncology at the National Cancer Institute in Bethesda, Maryland.

Dr. Poplack is a nationally recognized expert in the development of innovative therapies for pediatric cancer. He has received numerous awards and honors, including the Leukemia and Lymphoma Society Kenny Award, American Cancer Society Partners in Courage Award, United States Public Health Service Unit Commendation Award, Boston University School of Medicine Distinguished Alumni Award, United States Public Health Service Meritorious Service Medal and the United States Public Health Service Commendation Medal.

Dr. Poplack is co-editor of Principles and Practice of Pediatric Oncology, the leading textbook of pediatric oncology. He has written more than 355 original articles and book chapters in the field of pediatric oncology. He has served on many national and international committees, including panel appointments at the National Institutes of Health, the F.D.A. and the Institute of Medicine. Dr. Poplack was recently appointed to the National Cancer Institute’s Board of Scientific Counselors.